Private Equity

As its partnership with Rio Tinto's Nuton ends, Arizona Sonoran will independently advance its massive copper project, betting on strong economics.

With a massive IDR 200 billion capital boost from LDA Capital, Indonesian tech firm NANO is set to execute nearly IDR 5 trillion in contracts.

Twin Hospitality ousts CEO Kim Boerema, naming Chairman Andy Wiederhorn as his replacement to navigate a severe debt crisis and restructure the company.

High turnout and a peaceful vote mark CAR's election, but President Touadéra's quest for a third term raises questions about the nation's democratic future.

With a strong debut on the Hong Kong Stock Exchange, USAS Building System highlights growing investor faith in prefabricated industrial construction.

The nation's largest portable toilet provider files for pre-packaged bankruptcy, securing $1.1B to ensure operations continue without disruption.

Everybody Loves Languages' CEO and CFO are taking the company private, raising questions about minority shareholder value and the firm's future strategy.

Tevogen's Dr. Ryan Saadi donates over $88,000 in company stock to a UN-recognized charity, bolstering educational programs for underserved children.

Global marine supplier Wrist Group buys century-old Delaware Ship Supply, consolidating its power on the U.S. East Coast and ushering in a digital future.

A major acquisition turned sour, a 25% stock crash, and now a class action lawsuit. Inside Perrigo's costly infant formula venture and what it means.

After a series of operational disasters and market pressures, materials giant Ascend emerges from Chapter 11 with a clean slate and a plan to dominate.

Fourth-generation farmer John Melo brings large-scale operational expertise to the Dairy Council, poised to shape California's dairy sustainability and health initiatives.

Brock Purdy, CJ Stroud, and dozens of NFL stars are using their platform to demand U.S. intervention in Nigeria's escalating religious persecution crisis.

Charlesbank's strategic funding validates HBox’s 'clinic within a clinic' model, aiming to revolutionize care for high-risk chronic conditions.

Mirum raises over a quarter-billion dollars to acquire Bluejay Therapeutics, targeting a high-potential liver disease drug and signaling major growth.

In a landmark deal, BioMarin acquires Amicus Therapeutics, gaining high-growth drugs and reshaping the landscape for patients with rare genetic disorders.

A landmark executive order reclassifying cannabis is set to unleash a wave of biopharma innovation, validating science-first firms like Avicanna.

In a high-level diplomatic dinner, Argentina's ambassador showcased President Milei's sweeping reforms, signaling a new chapter for UK investment.

Facing a cash crunch, the Danish innovator seeks funds to survive, betting its future on a next-gen biotech solution to global water challenges.

The CEO of Genenta Science now owns 10% of the company, all bought on the open market. What does this bold insider move signal for its cancer therapy?